Inventor · disambiguated record
Jürgen Frevert
Also filed as: FREVERT JUERGEN · FREVERT JURGEN · FREVERT Jürgen
21 granted patents·8 pending applications·252 citations·filing 1999–2021
95Inventor score
Files withMERZ PHARMA GMBH & CO KGAA21FREVERT JURGEN3BIGALKE HANS1BIOTECON GES FUER BIO TECHNOLO1BIOTECON THERAPEUTICS GMBH1
Top patents by PatentIndex Score
29 records- 0192US9827298B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Nov 28, 2017·10 cites·4 claims
- 0290US9975929B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted May 22, 2018·6 cites·3 claims
- 0390US8398998B2Therapeutic composition comprising a botulinum neurotoxinBIGALKE HANS·Filed 2011·Granted Mar 19, 2013·33 cites·13 claims
- 0490US7829525B2Formulation for a protein pharmaceutical without added human serum albumin (HSA)MERZ PHARMA GMBH & CO KGAA·Filed 2004·Granted Nov 9, 2010·51 cites·22 claims
- 0589US8748151B2Clostridial neurotoxins with altered persistencyFREVERT JURGEN·Filed 2009·Granted Jun 10, 2014·17 cites·11 claims
- 0688US7964199B1Therapeutic composition comprising a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2000·Granted Jun 21, 2011·35 cites·8 claims
- 0786US9511114B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Dec 6, 2016·5 cites·5 claims
- 0885US6822076B2Hybrid protein for inhibiting the degranulation of mastocytes and the use thereofBIOTECON THERAPEUTICS GMBH·Filed 2002·Granted Nov 23, 2004·36 cites·11 claims
- 0983US10603353B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Mar 31, 2020·2 cites·27 claims
- 1080US9193771B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Nov 24, 2015·3 cites·3 claims
- 1179US9809809B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2012·Granted Nov 7, 2017·6 cites·17 claims
- 1279US8895713B2Clostridial neurotoxins with altered persistencyMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Nov 25, 2014·3 cites·5 claims
- 1379US8003601B2Pegylated mutated clostridium botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Aug 23, 2011·4 cites·28 claims
- 1471US9186396B2PEGylated mutated Clostridium botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Nov 17, 2015·1 cites·22 claims
- 1571US6573241B1Therapeutic agent for the suppression of snoring noisesBIOTECON GES FUER BIO TECHNOLO·Filed 1999·Granted Jun 3, 2003·38 cites·16 claims
- 1670US11078472B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Aug 3, 2021·1 cites·17 claims
- 1766US8586329B2Neurotoxins exhibiting shortened biological activityHOFMANN FRED·Filed 2010·Granted Nov 19, 2013·1 cites·11 claims
- 1861US2022010294A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2021·Application pending·0 cites
- 1958US8912140B2PEGylated mutated clostridium botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2012·Granted Dec 16, 2014·0 cites·8 claims
- 2054US11155802B2Recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Oct 26, 2021·0 cites·13 claims
- 2153US8298550B2PEGylated mutated Clostridium botulinum toxinFREVERT JURGEN·Filed 2011·Granted Oct 30, 2012·0 cites·2 claims
- 2249US2011217287A1Therapeutic composition comprising a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2011·Application pending·0 cites
- 2343US2015322118A1Recombinant clostridial neurotoxins with enhanced membrane localizationMERZ PHARMA GMBH & CO KGAA·Filed 2013·Application pending·0 cites
- 2442US2021008156A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
- 2541US11952601B2Recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Apr 9, 2024·0 cites·16 claims
- 2639US2014170133A1Alteration of proteolytic cleavage of botulinum neurotoxinsFREVERT JURGEN·Filed 2012·Application pending·0 cites
- 2739US2020354706A1Novel recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
- 2839US2015232828A1Method for the manufacturing of recombinant proteins harbouring an n-terminal lysineMERZ PHARMA GMBH & CO KGAA·Filed 2013·Application pending·0 cites
- 2938US2004028703A1Protein complex serving as a vehicle for orally administerable medicamentsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jürgen Frevert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →